BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs4950928, KLK3, G-protein-coupled receptor binding, Hepatitis, Pancreas, Lipitor)
Bookmark Forward

QuickView for Cbls (biogroup)


Body Atlas

Most Correlated Tissues

  1. Saphenous vein
  2. Spleen
  3. Vulva
  4. Trigeminal ganglia
  5. Lymph nodes
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Acute hepatic failure
  2. Hepatic failure
  3. Rift valley fever
  4. Autoimmune disease
  5. Infection due to Citrobacter
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Methylnitrosourea
  2. Pentetic Acid
  3. Menomune
  4. niguldipine
  5. tofacitinib
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MLXIPL
  2. RND1
  3. PPP2R2C
  4. CHUK
  5. TRAF3
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
  2. L1000 CMAP Liver cancer HEP G2 cells with gene overexpression perturbations
  3. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
  4. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
  5. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for Cbls
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
  2. A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas
  3. A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullnes…
  4. A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1)
  5. A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcuta…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.